Five Prime Therapeutics Inc
METHODS OF TREATMENT WITH CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES

Last updated:

Abstract:

This application relates to use of CD80 (B7-1) extracellular domain (ECD) polypeptides and CD80-ECD fusion molecules and their use in methods of increasing the number of central memory T cells or for treatment for cancer or for use in cancer vaccine compositions.

Status:
Application
Type:

Utility

Filling date:

27 Apr 2018

Issue date:

11 Jun 2020